Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke, J M
Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. [electronic resource] - Veterinary immunology and immunopathology May 2006 - 47-57 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
0165-2427
10.1016/j.vetimm.2006.01.008 doi
Adjuvants, Immunologic--pharmacology
Animals
Antibodies, Viral--blood
Female
Herpesviridae Infections--immunology
Herpesvirus 1, Equid--genetics
Herpesvirus Vaccines--genetics
Horse Diseases--immunology
Horses
Male
Neutralization Tests--veterinary
Polymerase Chain Reaction--veterinary
Statistics, Nonparametric
Vaccination--methods
Vaccines, DNA--immunology
Viral Envelope Proteins--genetics
Viral Vaccines--genetics
Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. [electronic resource] - Veterinary immunology and immunopathology May 2006 - 47-57 p. digital
Publication Type: Journal Article; Randomized Controlled Trial
0165-2427
10.1016/j.vetimm.2006.01.008 doi
Adjuvants, Immunologic--pharmacology
Animals
Antibodies, Viral--blood
Female
Herpesviridae Infections--immunology
Herpesvirus 1, Equid--genetics
Herpesvirus Vaccines--genetics
Horse Diseases--immunology
Horses
Male
Neutralization Tests--veterinary
Polymerase Chain Reaction--veterinary
Statistics, Nonparametric
Vaccination--methods
Vaccines, DNA--immunology
Viral Envelope Proteins--genetics
Viral Vaccines--genetics